Snowflake (SNOW) stock popped late Wednesday after the software maker's fourth-quarter earnings and revenue topped Wall Street targets while full-year fiscal 2026 guidance came in above expectations.
The enterprise software maker released its Snowflake earnings report after the market close.
↑ X NOW PLAYING How To Buy Stocks: IBD's Four Pillars Of InvestingOn an adjusted basis, Snowflake earnings were 30 cents per share, down 14% from a year earlier. Analysts expected Snowflake to report adjusted profit of 18 cents per share.
Revenue climbed 27% to $986.8 million, the enterprise software maker said. Analysts projected Q4 revenue of $956.9 million.
At RBC Capital, analyst Matthew Hedberg noted that Q4 revenue beat estimates by 3%, less than the 6% beat in Q3.
For fiscal 2026, Snowflake forecast product revenue growth of 24% to $4.28 billion vs. consensus estimates for 23% growth to $4.23 billion.
On the stock market today, Snowflake stock popped more than 11% to 184.87 in extended trading.
SNOW stock had advanced 10% in 2025 heading into the Snowflake earnings report after tumbling 22% last year.
Snowflake sells data analytics software that runs on cloud-computing platforms. Also, the company has evolved into a cloud data-management software provider.
Privately held Databricks is Snowflake's biggest rival.
According to IBD Stock Checkup, SNOW stock holds an IBD Composite Rating of 60 out of a best-possible 99. IBD's Composite Rating combines five separate proprietary ratings into one easy-to-use rating.
In addition, SNOW stock has an Accumulation/Distribution Rating of C. The rating, on an A+ to E scale, measures institutional buying and selling in a stock. A+ signifies heavy institutional buying; E means heavy selling.
Follow Reinhardt Krause on Twitter @reinhardtk_tech for updates on artificial intelligence, cybersecurity and cloud computing.
YOU MAY ALSO LIKE:
Learn The Best Trading Stock Rules From IBD's Investor's Corner
Want To Trade Options? Try Out These Strategies
Monitor IBD's "Breaking Out Today" List For Companies Hitting New Buy Points
IBD Digital: Unlock IBD's Premium Stock Lists, Tools And Analysis Today
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.